Jeffrey G. Spragens's most recent trade in SAB Biotherapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics Inc | Jeffrey G. Spragens | Director | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | ||
| SAB Biotherapeutics Inc | Jeffrey G. Spragens | Director | 28 Feb 2023 | 19,936 | 19,936 | - | - | Warrants | ||
| SAB Biotherapeutics Inc | Jeffrey G. Spragens | Director | 07 Dec 2022 | 82,987 | 82,987 | - | - | Warrant (Common Stock) | ||
| SAB Biotherapeutics Inc | Jeffrey G. Spragens | Director | 07 Dec 2022 | 82,987 | 394,989 | - | 1.2 | 99,999 | Common Stock | |
| SAB Biotherapeutics Inc | Jeffrey G. Spragens | Director | 20 May 2022 | 299,002 | 312,002 | - | 0 | Common Stock |